Market Cap (In KRW)
3417.32 Billion
Revenue (In KRW)
1490.88 Billion
Net Income (In KRW)
146.23 Billion
Avg. Volume
60.09 Thousand
- Currency
- KRW
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 243500.0-377000.0
- PE
- -
- EPS
- -
- Beta Value
- 0.47
- ISIN
- KR7128940004
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Jae-Hyun Park
- Employee Count
- -
- Website
- https://www.hanmipharm.com
- Ipo Date
- 2010-07-30
- Details
- Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
More Stocks
-
674191App, Inc.
6741
-
4991GCS Holdings, Inc.
4991
-
PDLB
-
ATYG
-
036460Korea Gas Corporation
036460
-
RHC
-
SSVC
-
MANAKCOAT